Skip to main content

Table 1 Baseline characteristics of patients with and without MACEs

From: Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome

Variables

Overall subjects (n = 6839)

MACEs (n = 462)

Without MACEs (n = 6377)

p value

Age, years

58.1 ± 10.7

63.1 ± 10.4

57.8 ± 10.6

< 0.001

Male, n (%)

4949 (72.4)

332 (71.9)

4617 (72.4)

0.836

Hypertension, n (%)

4212 (61.6)

316 (68.3)

3896 (61.1)

0.009

Diabetes, n (%)

1843 (27.0)

166 (36.0)

1677 (26.3)

< 0.001

Smoking status

0.184

 Never smoker, n (%)

3120 (45.6)

210 (45.5)

2910 (45.6)

 

 Former smoker, n (%)

929 (13.6)

77 (16.7)

852 (13.4)

 

 Current smoker, n (%)

2790 (40.8)

176 (38.0)

2614 (41.0)

 

Prior MI, n (%)

2053 (30.0)

191 (41.3)

1862 (29.2)

< 0.001

Prior RV, n (%)

1998 (29.2)

155 (33.5)

1843 (28.9)

0.073

Family history of CAD, n (%)

926 (13.5)

59 (12.8)

867 (13.6)

0.707

BMI, kg/m2

25.67 ± 3.19

25.50 ± 3.28

25.68 ± 3.18

0.309

SBP, mmHg

127 ± 17

129 ± 19

126 ± 17

0.019

DBP, mmHg

77 ± 11

76 ± 11

77 ± 11

0.025

LVEF, %

63.39 ± 8.15

59.84 ± 11.26

63.57 ± 7.92

< 0.001

Biochemical parameters

 FPG, mmol/L

5.75 ± 1.65

5.86 ± 1.87

5.75 ± 1.63

0.287

 HbA1c, %

6.27 ± 1.06

6.58 ± 1.24

6.26 ± 1.04

< 0.001

 TC, mmol/L

3.96 ± 1.03

4.00 ± 1.11

3.95 ± 1.03

0.469

 HDL-C, mmol/L

1.08 ± 0.29

1.08 ± 0.30

1.08 ± 0.29

0.894

 LDL-C, mmol/L

2.44 ± 0.92

2.44 ± 1.00

2.44 ± 0.92

0.991

 TG, mmol/L

1.33 (1.02–1.69)

1.31 (0.99–1.73)

1.33 (1.02–1.69)

0.878

 Lp(a), mg/dL

15.80 (7.11–37.87)

19.74 (8.93–43.75)

15.68 (7.05–37.61)

0.008

 RC, mmol/L

0.44 ± 0.24

0.48 ± 0.23

0.43 ± 0.24

0.001

 HsCRP, mg/L

1.31 (0.71–2.77)

1.62 (0.89–3.63)

1.29 (0.71–2.72)

< 0.001

 Creatinine, µmol/L

77.91 ± 18.57

80.84 ± 18.78

77.76 ± 18.55

0.003

  1. Continuous values are summarized as mean ± SD, median (interquartile range) and categorical variables as number (percentage)
  2. BMI body mass index, CAD coronary artery disease, DBP diastolic blood pressure, FPG fasting plasma glucose, HbA1c glycosylated hemoglobin, HDL-C high-density lipoprotein cholesterol, HsCRP high-sensitivity C-reactive protein, LVEF left ventricular ejection fraction, LDL-C low-density lipoprotein cholesterol, Lp(a) lipoprotein(a), MACEs major adverse cardiovascular events, MI myocardial infarction, RV revascularization, RC remnant cholesterol, SBP systolic blood pressure, TC total cholesterol, TG triglyceride